Public Citizen Accuses Pfizer of Building ‘Paxlovid Patent Wall,’ Pfizer Pushes Back Post author:PacConAdmin Post published:February 18, 2022 Post category:Drug Industry Daily The advocacy group Public Citizen is accusing Pfizer of building a “Paxlovid patent wall.” Source: Drug Industry Daily You Might Also Like EMA Revises 2009 Guideline on Axial Spondyloarthritis Treatments November 1, 2017 TGA Issues Risk Survey to Drugmakers Ahead of First Pharmacovigilance Inspections February 6, 2018 Sanofi and IGM Biosciences Ink Collaboration Agreement Potentially Worth $6 Billion March 29, 2022